Literature DB >> 7015133

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

P L Weiden, K M Sullivan, N Flournoy, R Storb, E D Thomas.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7015133     DOI： 10.1056/NEJM198106183042507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  159 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Authors:  Shoji Asakura; Daigo Hashimoto; Shuichiro Takashima; Haruko Sugiyama; Yoshinobu Maeda; Koichi Akashi; Mitsune Tanimoto; Takanori Teshima
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.

Authors:  H Nahi; M Remberger; M Machaczka; J Ungerstedt; J Mattson; O Ringden; Katarina Le-Blanc; P Ljungman; H Hägglund
Journal:  Med Oncol       Date:  2012-01-11       Impact factor: 3.064

Review 4.  Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.

Authors:  David H Sachs; Megan Sykes; Tatsuo Kawai; A Benedict Cosimi
Journal:  Semin Immunol       Date:  2011-08-11       Impact factor: 11.130

5.  Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

Authors:  J Gaschet; A Lim; L Liem; R Vivien; M M Hallet; J L Harousseau; J Even; E Goulmy; M Bonneville; N Milpied; H Vié
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

6.  Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

Authors:  E J Claret; E P Alyea; E Orsini; C C Pickett; H Collins; Y Wang; D Neuberg; R J Soiffer; J Ritz
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 7.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

Review 8.  Bone marrow transplantation: a review.

Authors:  R E Hardy; E V Ikpeazu
Journal:  J Natl Med Assoc       Date:  1989-05       Impact factor: 1.798

9.  T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.

Authors:  Joan How; Michael Slade; Khoan Vu; John F DiPersio; Peter Westervelt; Geoffrey L Uy; Camille N Abboud; Ravi Vij; Mark A Schroeder; Todd A Fehniger; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-10       Impact factor: 5.742

Review 10.  Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation.

Authors:  M F Siadak; K Kopecky; K M Sullivan
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.